Delivery Order SPE2DB24D2018-SPE2DB25FWVX1
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Uloric 80mg tablets. The award has a ceiling value of $2,990.19 and an ultimate completion date of November 20, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,345.53, is for the delivery of Uloric 40 mg tablets and has a period of performance through September 20, 2024. The contract is a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564450183 ULORIC 40 MG TABLET 30S. The $2,802.33 firm-fixed-price contract has a completion date of May 1, 2024 and was awarded on April 30, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,431.67 firm-fixed-price delivery order is for the supply of Uloric 40 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora to...
- This federal contract award, identified as SPE2DB20D2104|SPE2DB24FU92F, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,167.06 firm fixed-price delivery order is for the pharmaceutical product Uloric 40 mg tablet 30s. The contract has an ultimate completion date of June 28, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov)....
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,352.29 Firm Fixed Price delivery order contract is for the pharmaceutical product ULORIC 80 MG TABLET 30S, with a completion date of February 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,155.59, is for the delivery of ULORIC 40 MG TABLET 30S, a medication used to treat gout. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $636 delivery order to Amerisourcebergen Drug Corporation for 4562003785 ULORIC 80 MG TABLET 30S. The firm fixed price order is being fulfilled under the Prime Vendor Pharmaceuticals contract vehicle and will provide pharmaceutical products to DLA locations in the Conshohocken, Pennsylvania area from August 30 to August 31, 2023. Amerisourcebergen will perform as the prime contractor, with no subcontractors mentioned. The Defense Logistics Agency manages...
- This federal contract award is for the delivery of ULORIC 40 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,423.79 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 10, 2022, with a completion date of June 13, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide febuxostat 40 mg tablets. The $1,000.34 award has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor to the DLA, providing a range of pharmaceutical products and medical supplies to support military treatment programs and facilities. This...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWVX1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,580.18 to AmerisourceBergen Drug Corp for the supply of Uloric 80 mg tablets (30-count units) under a firm fixed-price contract type. The award was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and is classified as a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.99 million through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs and other federal healthcare systems worldwide. The company's consistent receipt of competitive delivery orders across diverse therapeutic domains, including specialty medications and brand-name drugs, reflects its established capability as a critical pharmaceutical distributor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/29/25 |